Literature DB >> 17335187

Enzymatically activated cycloSal-d4T-monophosphates: The third generation of cycloSal-pronucleotides.

Nicolas Gisch1, Jan Balzarini, Chris Meier.   

Abstract

The third generation of cycloSal-pronucleotides, 5-diacetoxymethyl-cycloSal-d4T-monophosphates (5-di-AM-cycloSal-d4TMPs), is reported as a new class of "lock-in"-modified cycloSal-pronucleotides. These compounds bear an esterase-cleavable geminal dicarboxylate (acylal) attached to the aromatic ring of the saligenyl unit. The conversion into a strong acceptor group (aldehyde) leads to a strong decrease in hydrolytic stability. As a consequence, a fast release of a nucleoside monophosphate (i.e., d4TMP) follows. The concept of this enzymatic activation is proven by hydrolysis studies in phosphate buffer, cell extracts, and human serum. These investigations showed the conversion of the acylal group into a polar aldehyde by enzymatic cleavage. Besides, antiviral activities against HIV are presented.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17335187     DOI: 10.1021/jm0613267

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  8 in total

Review 1.  Prodrugs of phosphonates and phosphates: crossing the membrane barrier.

Authors:  Andrew J Wiemer; David F Wiemer
Journal:  Top Curr Chem       Date:  2015

Review 2.  Synthesis of nucleoside phosphate and phosphonate prodrugs.

Authors:  Ugo Pradere; Ethel C Garnier-Amblard; Steven J Coats; Franck Amblard; Raymond F Schinazi
Journal:  Chem Rev       Date:  2014-08-21       Impact factor: 60.622

Review 3.  Prodrug approaches to improving the oral absorption of antiviral nucleotide analogues.

Authors:  Larryn W Peterson; Charles E McKenna
Journal:  Expert Opin Drug Deliv       Date:  2009-04       Impact factor: 6.648

4.  Treatment of breast and lung cancer cells with a N-7 benzyl guanosine monophosphate tryptamine phosphoramidate pronucleotide (4Ei-1) results in chemosensitization to gemcitabine and induced eIF4E proteasomal degradation.

Authors:  Shui Li; Yan Jia; Blake Jacobson; Joel McCauley; Robert Kratzke; Peter B Bitterman; Carston R Wagner
Journal:  Mol Pharm       Date:  2013-02-04       Impact factor: 4.939

5.  Enantioselective Vanadium-Catalyzed Oxidative Coupling: Development and Mechanistic Insights.

Authors:  Houng Kang; Madison R Herling; Kyle A Niederer; Young Eun Lee; Peddiahgari Vasu Govardhana Reddy; Sangeeta Dey; Scott E Allen; Paul Sung; Kirsten Hewitt; Carilyn Torruellas; Gina J Kim; Marisa C Kozlowski
Journal:  J Org Chem       Date:  2018-11-14       Impact factor: 4.354

6.  Vanadium-catalyzed regioselective oxidative coupling of 2-hydroxycarbazoles.

Authors:  Lei Liu; Patrick J Carroll; Marisa C Kozlowski
Journal:  Org Lett       Date:  2015-01-15       Impact factor: 6.005

7.  Robust bifunctional aluminium-salen catalysts for the preparation of cyclic carbonates from carbon dioxide and epoxides.

Authors:  Yuri A Rulev; Zalina Gugkaeva; Victor I Maleev; Michael North; Yuri N Belokon
Journal:  Beilstein J Org Chem       Date:  2015-09-11       Impact factor: 2.883

8.  Scalable Synthesis and Cancer Cell Cytotoxicity of Rooperol and Analogues.

Authors:  Zachary T Schwartz; Peter D Theisen; Olaf T Bjornstal; Mary Rodebaugh; Mauricio A Jemal; Dallas Lee; Spencer D Shelton; Zhenze Zhao; Liqin Du; Sean M Kerwin
Journal:  Molecules       Date:  2022-03-09       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.